Biolyst › BSXCash runway
Cash generating
BOSTON SCIENTIFIC CORP is tracked here for clinical trial milestones, SEC filings and earnings dates. Focus area: Surgical & Medical Instruments & Apparatus.
The next scheduled catalyst is Next quarterly earnings (projected) on October 28, 2026, a projected date rather than a confirmed one. There are 3 upcoming events on record.
BOSTON SCIENTIFIC CORP generates cash from operations, so a burn-based runway figure does not apply.
Across 345 concluded trials, 84% reached completion rather than being terminated or withdrawn.
Track BSX alongside other companies. Add it to a watchlist and see every catalyst on one calendar.
Open BSX in the tracker
Recent history
Date Event Type Phase
October 7, 2026
8-K filed: Leadership change, Other event Corporate
—
September 23, 2026
8-K filed: Leadership change Corporate
—
August 26, 2026
8-K filed: Other event Filing
—
July 29, 2026
Quarterly results filed (8-K) Earnings
—
May 18, 2026
8-K filed: Other event Filing
—
May 18, 2026
8-K filed: Other event Filing
—
April 22, 2026
Quarterly results filed (8-K) Earnings
—
March 30, 2026
8-K filed: Other event Filing
—
February 26, 2026
8-K filed: Material agreement Corporate
—
February 23, 2026
8-K filed: Leadership change, Reg FD disclosure, Other event Corporate
—
February 5, 2026
8-K filed: Leadership change Corporate
—
February 4, 2026
Quarterly results filed (8-K) Earnings
—
January 15, 2026
8-K filed: Reg FD disclosure Filing
—
January 15, 2026
8-K filed: Material agreement Corporate
—
November 19, 2025
8-K filed: Leadership change Corporate
—
October 23, 2025
8-K filed: Leadership change Corporate
—
October 22, 2025
Quarterly results filed (8-K) Earnings
—
September 4, 2025
8-K filed: Leadership change Corporate
—
July 23, 2025
Quarterly results filed (8-K) Earnings
—
May 28, 2025
8-K filed: Other event Filing
—
April 23, 2025
Quarterly results filed (8-K) Earnings
—
April 23, 2025
8-K filed: Leadership change, Other event Corporate
—
April 4, 2024
Varithena Versus Endothermal Ablation of the Great Saphenous Vein (VERITAS) Trial Milestone
Phase 4
October 2, 2023
A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) Trial Milestone
Phase 3
April 21, 2022
The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia Trial Milestone
Phase 3
January 16, 2020
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s) Trial Milestone
Phase 3
November 18, 2019
RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty Trial Milestone
Phase 3
August 3, 2019
Vandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver Malignancies Trial Milestone
EARLY_Phase 1
April 30, 2019
Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism Trial Milestone
Phase 4
June 5, 2017
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma Trial Milestone
Phase 3
About this data
Trial milestones come from the ClinicalTrials.gov v2 API, filings from SEC EDGAR, and financial figures from SEC XBRL company facts. Dates marked est. are projected rather than company-confirmed. This is an information tool, not investment advice — verify anything you act on against the linked primary source.
Last updated 2026-10-14.